Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

8 articles from the last 30 days matching "mutations"

ResearchBIORXIVToday

Preprint: Genotype-Based Severity Scoring System in Wolfram Syndrome

Wolfram syndrome is a rare genetic disorder that causes diabetes, vision loss, hearing loss, and brain problems. Researchers created a new scoring system that looks at the specific genetic mutations in the WFS1 gene to predict how severe a patient's symptoms will be and when they might appear. This system could help doctors understand what to expect for each patient based on their individual genetic makeup.

WHY IT MATTERSIf validated, this genotype-based scoring system could allow doctors to predict disease progression and symptom onset in individual Wolfram syndrome patients, enabling earlier intervention and personalized monitoring strategies.
Good to knowWolfram syndromeRead →
ResearchRSS3 days ago

Spontaneous mutations may underlie some sporadic ALS cases

Scientists discovered that some people with ALS (a disease that affects nerve cells controlling muscles) may develop the condition from new mutations that happen by chance in their nerve cells, rather than inheriting the mutation from their parents. This is different from inherited ALS cases where a parent passes down a faulty gene. This finding suggests there are multiple ways ALS can develop, which could help doctors better understand and treat the disease.

WHY IT MATTERSIf your ALS diagnosis is sporadic (not inherited), this research suggests your condition may have developed from random mutations in your nerve cells rather than a genetic predisposition, which could change how doctors approach your treatment and genetic counseling.
Good to knowAmyotrophic Lateral Sclerosis (ALS)Read →
ResearchPUBMEDApr 16

Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation.

Scientists created a new tool called STRIPE that uses advanced genetic testing to read long strands of RNA (the instructions cells use to make proteins). This tool can detect genetic mistakes that cause rare diseases by looking at how genes are actually working in cells, not just finding the mutations themselves. It's designed to be faster, cheaper, and more practical than older methods, which could help doctors diagnose rare genetic diseases that are hard to identify.

WHY IT MATTERSPatients with undiagnosed rare genetic diseases could finally get answers through more accurate genetic testing, since STRIPE can detect disease-causing variants that standard DNA tests might miss.
Good to knowRead →
ResearchPUBMEDApr 14

Rare genetic diseases associated with G-quadruplex-induced replication stress.

Scientists have discovered that certain rare genetic diseases are caused by mutations in genes that help cells copy their DNA. These genes normally produce proteins that untangle special twisted DNA structures called G-quadruplexes that get in the way during copying. When these proteins don't work properly, cells can't copy their DNA correctly, leading to problems like weak immune systems, slow growth, birth defects, and increased cancer risk.

WHY IT MATTERSUnderstanding which genes cause these G-quadruplex problems could help doctors diagnose patients with unexplained immunodeficiency, growth delays, or birth defects, and may eventually lead to targeted treatments for these currently untreatable conditions.
Good to knowRead →
ResearchBIORXIVApr 12

Preprint: Complementary vertebrate Wac models exhibit phenotypes relevant to DeSanto-Shinawi Syndrome

Scientists created animal models (using fish and mice) that mimic DeSanto-Shinawi Syndrome, a rare genetic disorder caused by mutations in the WAC gene. These animal models showed symptoms similar to what patients experience, including developmental delays, intellectual disability, autism-like behaviors, and seizures. This research helps scientists understand how WAC gene mutations cause these symptoms and could lead to better treatments in the future.

WHY IT MATTERSFor the first time, researchers have created animal models that reproduce the key symptoms of DeSanto-Shinawi Syndrome, which could accelerate the discovery of why patients develop autism, seizures, and developmental delays—and potentially identify new treatment targets.
👁 Watch this spaceDeSanto-Shinawi SyndromeRead →
ResearchBIORXIVApr 2

Preprint: Ultra-rare biallelic THAP12 variants cause loss of function and underlie severe epileptic encephalopathy

Researchers discovered that mutations in a gene called THAP12 cause a severe type of childhood epilepsy called developmental and epileptic encephalopathy. Two siblings with this condition had two broken copies of the THAP12 gene (one from each parent), which stopped the gene from making enough of its protein. This finding helps explain why some children develop severe seizures early in life and could lead to better diagnosis and treatment options.

WHY IT MATTERSFamilies with children diagnosed with infantile spasms or Lennox-Gastaut syndrome now have a new genetic cause to test for, which could explain their child's condition and guide future treatment decisions.
💬 Ask your doctorDevelopmental and Epileptic Encephalopathy (DEE)Infantile SpasmsLennox-Gastaut SyndromeRead →
ResearchPUBMEDMar 28

Macrophage Extracellular Vesicles: Therapeutic Strategies for Corneal Fibrosis in Rare Diseases.

Scientists are studying a new way to treat corneal scarring (clouding of the eye that causes blindness) using tiny particles called extracellular vesicles that come from immune cells called macrophages. This approach is being tested for rare genetic eye diseases like epidermolysis bullosa, KID syndrome, and aniridia, where the cornea becomes scarred due to chronic inflammation and genetic mutations. Current treatments don't work well and have significant side effects, so this new method could offer patients a better option.

WHY IT MATTERSFor patients with epidermolysis bullosa, KID syndrome, or aniridia experiencing corneal scarring, this research offers a potential new treatment strategy that could prevent blindness without the side effects of current therapies.
Good to knowepidermolysis bullosakeratitis-ichthyosis-deafness syndromeaniridiaRead →
ResearchPUBMEDMar 28

From Genomic Diagnosis to Personalized RNA Medicine: Advances in Next-Generation Sequencing and N-of-1 Antisense Oligonucleotide Therapies for Rare Genetic Diseases.

Scientists are getting better at finding rare genetic diseases using a tool called next-generation sequencing, which can read a person's DNA quickly and accurately. They're also developing new medicines called antisense oligonucleotides that can be customized for each patient to fix problems caused by genetic mutations. Together, these advances mean doctors can diagnose rare diseases faster and create personalized treatments tailored to each person's specific genetic makeup.

WHY IT MATTERSThis research shows a clear path for patients with rare genetic diseases to move from diagnosis to personalized treatment within a single medical framework, potentially reducing the diagnostic odyssey that currently takes years for many rare disease patients.
Good to knowrare monogenic disordersrare genetic diseasesRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases